Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.72T | 14.03T | 13.95T | 12.29T | 10.36T |
Gross Profit | 2.38T | 2.23T | 2.13T | 1.94T | 1.78T |
EBITDA | 1.36T | 1.29T | 1.25T | 1.28T | 968.57B |
Net Income | 880.25B | 801.77B | 800.52B | 820.27B | 401.43B |
Balance Sheet | |||||
Total Assets | 15.13T | 14.49T | 13.11T | 12.15T | 11.18T |
Cash, Cash Equivalents and Short-Term Investments | 589.49B | 689.06B | 688.80B | 724.83B | 598.88B |
Total Debt | 4.62T | 4.40T | 4.01T | 3.92T | 4.22T |
Total Liabilities | 8.84T | 8.50T | 7.65T | 7.39T | 7.31T |
Stockholders Equity | 5.76T | 5.43T | 4.82T | 4.20T | 3.32T |
Cash Flow | |||||
Free Cash Flow | 804.64B | 775.56B | 743.98B | 644.02B | 730.88B |
Operating Cash Flow | 997.28B | 978.11B | 938.06B | 801.16B | 895.90B |
Investing Cash Flow | -516.27B | -205.99B | -453.81B | 38.64B | -207.30B |
Financing Cash Flow | -525.00B | -413.33B | -500.08B | -846.71B | -728.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $3.38T | 9.29 | 14.04% | 3.45% | 1.18% | 9.37% | |
80 Outperform | ¥11.28T | 12.25 | 10.17% | 3.44% | -4.85% | 2.78% | |
79 Outperform | ¥4.45T | 7.93 | 12.19% | 3.53% | 5.52% | 46.81% | |
78 Outperform | $4.96T | 9.77 | 13.98% | 3.38% | 7.44% | 8.25% | |
77 Outperform | ¥10.90T | 12.30 | 15.55% | 2.64% | 4.95% | 11.33% | |
76 Outperform | $8.55T | 9.77 | 11.74% | 3.34% | 10.04% | -13.06% | |
71 Outperform | ¥252.71B | 13.12 | 8.49% | 3.08% | 6.31% | 13.02% |